# Individualized Drug Simulation **Entity class:** Computational medicine concept **Domain:** Precision medicine / Drug discovery **Maturity:** Developed ## Definition Individualized drug simulation predicts how a proposed treatment may affect a particular person's modeled cells, tissues, or physiological state. ## Mechanism and significance Its clinical ambition is to narrow treatment choices before exposure, but a simulated response must be validated against the biological scales and outcomes that matter for the patient. ## Relationships - **Research dossier:** [[research/ASI and RSI Timeline Research Moonshots|ASI and RSI Timeline Research Moonshots]] - **Ontology route:** [[ASI and RSI Timeline Ontology#Computational Biology and Virtual Cells|Computational Biology and Virtual Cells]] - **Primary fields:** [[AI-Driven Biology]] · [[Cellular Digital Twins]] · [[Computational Biology]] - **Adjacent concepts:** [[Protein-State Measurement]] · [[Nondestructive Cellular Measurement]] · [[Biological Foundation Model]] · [[Organoid System]] ## Sources and provenance - [[research/ASI and RSI Timeline Research Moonshots|ASI and RSI Timeline Research Moonshots]] — immediate source for this node's role in the broadcast research map. ## Evidence boundary The research dossier establishes why this entity or concept belongs in the Moonshots ontology. Time-sensitive organizational, product, policy, and performance claims should be checked against the linked primary source or a current authoritative source before reuse as settled fact.